Provis Biolabs

Provis Biolabs is a fast-growing biotechnology company specializing in animal-origin-free bioreagents for global pharmaceutical and biopharmaceutical applications. Founded in 2019, we have commercialized 10 products and continue to expand our robust pipeline. Our mission is to address unmet needs in life sciences research and therapeutic development by delivering high-quality and reliable solutions. Backed by WHO-GMP, GLP, ISO 9001:2015, Halal and Kosher certifications, we offer end-to-end capabilities spanning R&D to GMP manufacturing. Leveraging our state-of-the-art fermentation facility, we provide scalable production solutions to partners worldwide. Our expertise covers critical areas such as vaccines and biologics, monoclonal antibodies (mAbs), cell culture and cell and gene therapy products, ensuring versatile support for diverse industry demands. Provis Biolabs serves as a Contract Development and Manufacturing Organization (CDMO), offering specialized fermentation-based development and manufacturing services. We guide partners through every stage—from clone development and strain engineering to process optimization, scale-up and commercial manufacturing. Provis Biolabs is poised to be a global leader in the life sciences industry by delivering superior quality products and solutions to improve health and environment through sustainable means.